We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Highly Sensitive ELISA Technique for Bevacizumab Bioanalysis

News   Feb 01, 2018 | Original story from Bentham Science Publishers

 
Highly Sensitive ELISA Technique for Bevacizumab Bioanalysis

This is a schematic diagram of the ELISA for Bevacizumab. Credit: Bentham Science Publishers and Dr. Manal A. El-Gendy et al.

 
 
 

RELATED ARTICLES

Revival of 50,000-Year-Old Gene Reveals How Deadliest Malaria Parasite Jumped from Gorillas to Humans

News

In a study published today in PLOS Biology, researchers from the Wellcome Sanger Institute and the University of Montpellier have reconstructed a ~50,000-year-old gene sequence acquired by the ancestor of Plasmodium falciparum. The acquisition of the gene sequence enabled the parasite to infect human red blood cells.

READ MORE

Fungus Chemistry May Mimic Opioids With Fewer Side Effects

News

The hunt for an opioid alternative has made a leap forward – a unique fungus may be able to mimic opioid suggesting it could be a safer less addictive drug, helping address the opioid epidemic of deaths by overdose.

READ MORE

Post-surgery Surveillance – Less May Be More for Low-risk Thyroid Cancer Patients

News

A study has found that some patients, known as maximizers, consume a high level of medical resources without clear evidence of better outcomes.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE